NCT00019032View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 1996

Conditions
Leukemia
Interventions
BIOLOGICAL

monoclonal antibody Mik-beta-1

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019032 - Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter